| - GRCh37:
- Chr3:45921375-50787353
- GRCh38:
- Chr3:45879883-50749922
| ALS2CL, AMIGO3, AMT, APEH, ARIH2, ARIH2OS, ATRIP, ATRIP-TREX1, BSN, BSN-DT, C3orf18, C3orf62, C3orf84, CACNA2D2, CAMKV, CAMP, CCDC12, CCDC51, CCDC71, CCR1, CCR2, CCR3, CCR5, CCR5AS, CCR9, CCRL2, CDC25A, CDHR4, CELSR3, CISH, COL7A1, CRIPTO, CSPG5, CXCR6, CYB561D2, DAG1, DALRD3, DHX30, DOCK3, ELP6, FAM240A, FBXW12, FYCO1, GMPPB, GNAI2, GNAT1, GPX1, HEMK1, HYAL1, HYAL2, HYAL3, IFRD2, IHO1, IMPDH2, INKA1, IP6K1, IP6K2, KIF9, KIF9-AS1, KLHDC8B, KLHL18, LAMB2, LINC02009, LINC02019, LINC02585, LOC101928965, LOC110121200, LOC111591507, LOC112935943, LOC112935944, LOC112935945, LOC112935946, LOC115995510, LOC119086083, LOC121009664, LOC121009665, LOC121009666, LOC121009667, LOC121009668, LOC121009669, LOC121009670, LOC121009671, LOC121725144, LOC122889078, LOC122889079, LOC122889080, LOC122889081, LOC122889082, LOC122889083, LOC122889084, LOC122889085, LOC122889086, LOC122889087, LOC122889088, LOC126806671, LOC126806672, LOC126806673, LOC126806674, LOC126806675, LOC126806676, LOC127898564, LRRC2, LRRC2-AS1, LSMEM2, LTF, LZTFL1, MAP4, MAPKAPK3, MIR1226, MIR191, MIR2115, MIR425, MIR4271, MIR4443, MIR4787, MIR4793, MIR5193, MIR566, MIR5787, MIR6823, MIR6824, MIR6872, MIR6890, MIR711, MON1A, MST1, MST1R, MYL3, NAA80, NBEAL2, NCKIPSD, NDUFAF3, NICN1, NME6, NPRL2, P4HTM, PFKFB4, PLXNB1, PRKAR2A, PRKAR2A-AS1, PRSS50, PTH1R, PTPN23, QARS1, QRICH1, RASSF1, RASSF1-AS1, RBM5, RBM5-AS1, RBM6, RHOA, RNF123, RTP3, SCAP, SEMA3B, SEMA3B-AS1, SEMA3F, SEMA3F-AS1, SETD2, SHISA5, SLC25A20, SLC26A6, SLC38A3, SMARCC1, SNORA94, SNORD13J, SNORD146, SPINK8, TCTA, TMA7, TMEM115, TMEM89, TMIE, TRAIP, TREX1, TUSC2, UBA7, UCN2, UQCRC1, USP19, USP4, WDR6, XCR1, ZMYND10, ZNF589 | | See cases | Pathogenic (Sep 23, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr3:46768104-47009805
- GRCh38:
- Chr3:46726614-46968315
| CCDC12, LOC112935943, LOC121009666, LOC122889081, MYL3, PTH1R | | See cases | Pathogenic (Aug 13, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr3:46899400
- GRCh38:
- Chr3:46857910
| MYL3 | | Hypertrophic cardiomyopathy | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899465
- GRCh38:
- Chr3:46857975
| MYL3 | | Hypertrophic cardiomyopathy 8 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899493
- GRCh38:
- Chr3:46858003
| MYL3 | | Hypertrophic cardiomyopathy 8 | Uncertain significance (Aug 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899516
- GRCh38:
- Chr3:46858026
| MYL3 | | Hypertrophic cardiomyopathy 8, not provided | Benign (Jun 26, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899578
- GRCh38:
- Chr3:46858088
| MYL3 | | not specified | Likely benign (May 24, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899681
- GRCh38:
- Chr3:46858191
| MYL3 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899716
- GRCh38:
- Chr3:46858226
| MYL3 | | not specified, Hypertrophic cardiomyopathy 8, Cardiomyopathy
| Likely benign (Aug 28, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899721
- GRCh38:
- Chr3:46858231
| MYL3 | | Hypertrophic cardiomyopathy 8 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899725
- GRCh38:
- Chr3:46858235
| MYL3 | | not specified | Benign (May 27, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899728
- GRCh38:
- Chr3:46858238
| MYL3 | | Cardiomyopathy | Uncertain significance (Jun 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899729
- GRCh38:
- Chr3:46858239
| MYL3 | | not specified, Cardiomyopathy, Hypertrophic cardiomyopathy 8
| Conflicting interpretations of pathogenicity (Nov 20, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:46899731
- GRCh38:
- Chr3:46858241
| MYL3 | | Cardiomyopathy | Benign (Jan 28, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899740
- GRCh38:
- Chr3:46858250
| MYL3 | | Cardiomyopathy | Likely benign (Mar 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899743
- GRCh38:
- Chr3:46858253
| MYL3 | M193fs | Hypertrophic cardiomyopathy | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899743
- GRCh38:
- Chr3:46858253
| MYL3 | M193I | Hypertrophic cardiomyopathy | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899745
- GRCh38:
- Chr3:46858255
| MYL3 | M193V | Cardiomyopathy | Uncertain significance (Feb 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899746-46899747
- GRCh38:
- Chr3:46858256-46858257
| MYL3 | M193fs | Cardiovascular phenotype, Hypertrophic cardiomyopathy | Uncertain significance (Feb 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899747
- GRCh38:
- Chr3:46858257
| MYL3 | I129N, I134N, I192N | Hypertrophic cardiomyopathy | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899751
- GRCh38:
- Chr3:46858261
| MYL3 | H191D | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Sep 1, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899754
- GRCh38:
- Chr3:46858264
| MYL3 | K190E | Hypertrophic cardiomyopathy, not provided | Uncertain significance (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899755
- GRCh38:
- Chr3:46858265
| MYL3 | | Cardiomyopathy | Likely benign (Dec 2, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899763
- GRCh38:
- Chr3:46858273
| MYL3 | | Hypertrophic cardiomyopathy | Uncertain significance (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899763
- GRCh38:
- Chr3:46858273
| MYL3 | | Cardiomyopathy | Uncertain significance (May 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899764
- GRCh38:
- Chr3:46858274
| MYL3 | | Hypertrophic cardiomyopathy | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899765
- GRCh38:
- Chr3:46858275
| MYL3 | | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Jan 26, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899769
- GRCh38:
- Chr3:46858279
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899772
- GRCh38:
- Chr3:46858282
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (Jul 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899776-46899777
- GRCh38:
- Chr3:46858286-46858287
| MYL3 | | Cardiomyopathy | Likely benign (Oct 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899777
- GRCh38:
- Chr3:46858287
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899777
- GRCh38:
- Chr3:46858287
| MYL3 | | Hypertrophic cardiomyopathy, Cardiomyopathy | Conflicting interpretations of pathogenicity (Jul 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:46899792
- GRCh38:
- Chr3:46858302
| MYL3 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899843-46899858
- GRCh38:
- Chr3:46858353-46858368
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899855
- GRCh38:
- Chr3:46858365
| MYL3 | | not specified, Hypertrophic cardiomyopathy | Benign (Sep 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899868
- GRCh38:
- Chr3:46858378
| MYL3 | | not specified, Cardiomyopathy, Hypertrophic cardiomyopathy
| Benign/Likely benign (Oct 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899872
- GRCh38:
- Chr3:46858382
| MYL3 | | Hypertrophic cardiomyopathy | Uncertain significance (Jul 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899876
- GRCh38:
- Chr3:46858386
| MYL3 | E186A | Hypertrophic cardiomyopathy 8, not provided, Cardiomyopathy
| Uncertain significance (Feb 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899878
- GRCh38:
- Chr3:46858388
| MYL3 | | Cardiomyopathy | Likely benign (Feb 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899880
- GRCh38:
- Chr3:46858390
| MYL3 | Y185N | Hypertrophic cardiomyopathy | Uncertain significance (Aug 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899881
- GRCh38:
- Chr3:46858391
| MYL3 | | Cardiovascular phenotype, Hypertrophic cardiomyopathy, Cardiomyopathy
| Likely benign (Nov 18, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899884
- GRCh38:
- Chr3:46858394
| MYL3 | | Cardiomyopathy, Hypertrophic cardiomyopathy, Cardiovascular phenotype, not specified | Likely benign (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899887
- GRCh38:
- Chr3:46858397
| MYL3 | | Cardiomyopathy | Likely benign (Nov 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899894
- GRCh38:
- Chr3:46858404
| MYL3 | N180S | Hypertrophic cardiomyopathy, Cardiomyopathy | Uncertain significance (Sep 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899897
- GRCh38:
- Chr3:46858407
| MYL3 | S179F | Hypertrophic cardiomyopathy | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899897
- GRCh38:
- Chr3:46858407
| MYL3 | S179Y | Hypertrophic cardiomyopathy | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899901
- GRCh38:
- Chr3:46858411
| MYL3 | D178N | Cardiovascular phenotype, not provided, not specified, Cardiomyopathy, Hypertrophic cardiomyopathy | Conflicting interpretations of pathogenicity (Dec 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:46899903
- GRCh38:
- Chr3:46858413
| MYL3 | E177G | Cardiovascular phenotype, not specified, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy
| Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899912
- GRCh38:
- Chr3:46858422
| MYL3 | A174V | Cardiomyopathy | Uncertain significance (Oct 4, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899913
- GRCh38:
- Chr3:46858423
| MYL3 | A174P | not specified, Cardiomyopathy | Uncertain significance (Nov 9, 2017) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899915
- GRCh38:
- Chr3:46858425
| MYL3 | M173T | not provided, Hypertrophic cardiomyopathy, Cardiovascular phenotype
| Uncertain significance (Nov 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899915
- GRCh38:
- Chr3:46858425
| MYL3 | M173K | Hypertrophic cardiomyopathy, not provided | Conflicting interpretations of pathogenicity (Mar 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:46899916
- GRCh38:
- Chr3:46858426
| MYL3 | M173V | Cardiomyopathy, not specified, not provided, Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy | Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899917
- GRCh38:
- Chr3:46858427
| MYL3 | | Cardiovascular phenotype, not specified, Cardiomyopathy, Hypertrophic cardiomyopathy | Likely benign (May 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899919
- GRCh38:
- Chr3:46858429
| MYL3 | | Cardiomyopathy, Hypertrophic cardiomyopathy | Likely benign (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899925
- GRCh38:
- Chr3:46858435
| MYL3 | E170Q | Hypertrophic cardiomyopathy, Cardiovascular phenotype | Uncertain significance (Sep 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899925
- GRCh38:
- Chr3:46858435
| MYL3 | E170K | Hypertrophic cardiomyopathy | Uncertain significance (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899926
- GRCh38:
- Chr3:46858436
| MYL3 | | Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy | Likely benign (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899928
- GRCh38:
- Chr3:46858438
| MYL3 | V106M, V169M, V111M | Hypertrophic cardiomyopathy | Uncertain significance (Apr 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899928
- GRCh38:
- Chr3:46858438
| MYL3 | V111L, V106L, V169L | Hypertrophic cardiomyopathy | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899929
- GRCh38:
- Chr3:46858439
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (May 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899930
- GRCh38:
- Chr3:46858440
| MYL3 | E110A, E168A, E105A | Hypertrophic cardiomyopathy | Uncertain significance (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899931
- GRCh38:
- Chr3:46858441
| MYL3 | E168K | Cardiomyopathy | Uncertain significance (Dec 7, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899932
- GRCh38:
- Chr3:46858442
| MYL3 | | not specified, Cardiomyopathy, Hypertrophic cardiomyopathy
| Likely benign (May 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899934
- GRCh38:
- Chr3:46858444
| MYL3 | D167N | Cardiovascular phenotype, Cardiomyopathy | Uncertain significance (Mar 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899939
- GRCh38:
- Chr3:46858449
| MYL3 | T165R | Hypertrophic cardiomyopathy | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899945
- GRCh38:
- Chr3:46858455
| MYL3 | R163K | Cardiomyopathy | Uncertain significance (Mar 7, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899946
- GRCh38:
- Chr3:46858456
| MYL3 | R163G | Cardiovascular phenotype, Hypertrophic cardiomyopathy | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899947
- GRCh38:
- Chr3:46858457
| MYL3 | E104D, E162D | Hypertrophic cardiomyopathy | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899949
- GRCh38:
- Chr3:46858459
| MYL3 | E162K | Cardiomyopathy | Uncertain significance (Oct 25, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899950
- GRCh38:
- Chr3:46858460
| MYL3 | | Hypertrophic cardiomyopathy, Cardiomyopathy | Likely benign (Aug 18, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899951
- GRCh38:
- Chr3:46858461
| MYL3 | G161D | not specified | Uncertain significance (Nov 11, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899952
- GRCh38:
- Chr3:46858462
| MYL3 | | not specified | Uncertain significance (Oct 15, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899953
- GRCh38:
- Chr3:46858463
| MYL3 | | not provided | not provided | no assertion provided |
| - GRCh37:
- Chr3:46899957
- GRCh38:
- Chr3:46858467
| MYL3 | | Primary familial hypertrophic cardiomyopathy | Uncertain significance (Nov 25, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:46899960
- GRCh38:
- Chr3:46858470
| MYL3 | | Cardiomyopathy | Uncertain significance (Oct 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46899961
- GRCh38:
- Chr3:46858471
| MYL3 | | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:46899965
- GRCh38:
- Chr3:46858475
| MYL3 | | not specified, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy | Benign/Likely benign (Oct 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899968
- GRCh38:
- Chr3:46858478
| MYL3 | | not specified, Hypertrophic cardiomyopathy | Benign/Likely benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46899969
- GRCh38:
- Chr3:46858479
| MYL3 | | not provided | Likely benign | no assertion criteria provided |
| - GRCh37:
- Chr3:46899971
- GRCh38:
- Chr3:46858481
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900051
- GRCh38:
- Chr3:46858561
| MYL3 | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900950
- GRCh38:
- Chr3:46859460
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (Aug 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900955
- GRCh38:
- Chr3:46859465
| MYL3 | | Hypertrophic cardiomyopathy | Likely benign (Nov 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900960
- GRCh38:
- Chr3:46859470
| MYL3 | | Cardiovascular phenotype, Hypertrophic cardiomyopathy | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900965
- GRCh38:
- Chr3:46859475
| MYL3 | G103S, E103K, G161S | Hypertrophic cardiomyopathy | Uncertain significance (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900965
- GRCh38:
- Chr3:46859475
| MYL3 | G161C | Hypertrophic cardiomyopathy 8 | Uncertain significance (Mar 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900969
- GRCh38:
- Chr3:46859479
| MYL3 | | Cardiomyopathy, Hypertrophic cardiomyopathy, not provided, Cardiovascular phenotype | Likely benign (Jul 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900969
- GRCh38:
- Chr3:46859479
| MYL3 | | not specified, Cardiomyopathy, Cardiovascular phenotype, Hypertrophic cardiomyopathy | Benign/Likely benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900970
- GRCh38:
- Chr3:46859480
| MYL3 | T159M | Cardiovascular phenotype, Hypertrophic cardiomyopathy, Cardiomyopathy
| Uncertain significance (Sep 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900971
- GRCh38:
- Chr3:46859481
| MYL3 | T101S, T159S | Cardiovascular phenotype | Uncertain significance (Aug 28, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900980
- GRCh38:
- Chr3:46859490
| MYL3 | V156L | Hypertrophic cardiomyopathy, Restrictive cardiomyopathy, Hypertrophic cardiomyopathy
| Uncertain significance (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900980
- GRCh38:
- Chr3:46859490
| MYL3 | V156L | not specified, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 8, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy
| Conflicting interpretations of pathogenicity (Oct 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:46900980
- GRCh38:
- Chr3:46859490
| MYL3 | V156M | Cardiovascular phenotype, not specified, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 8, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy | Conflicting interpretations of pathogenicity (Aug 28, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:46900981
- GRCh38:
- Chr3:46859491
| MYL3 | | not specified, Cardiomyopathy, Cardiovascular phenotype, Hypertrophic cardiomyopathy | Likely benign (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900982
- GRCh38:
- Chr3:46859492
| MYL3 | H97L, H155L | Hypertrophic cardiomyopathy | Uncertain significance (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:46900983
- GRCh38:
- Chr3:46859493
| MYL3 | H155D | not provided, Hypertrophic cardiomyopathy | Conflicting interpretations of pathogenicity (May 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:46900985
- GRCh38:
- Chr3:46859495
| MYL3 | R154H | Cardiovascular phenotype, not specified, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy
| Uncertain significance (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900986
- GRCh38:
- Chr3:46859496
| MYL3 | R154C | Cardiovascular phenotype, not specified, Cardiomyopathy, Hypertrophic cardiomyopathy | Uncertain significance (Oct 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:46900988-46900992
- GRCh38:
- Chr3:46859498-46859502
| MYL3 | | Hypertrophic cardiomyopathy | Uncertain significance (May 14, 2022) | criteria provided, single submitter |